Overview

Study of WPV01 in Healthy Subjects

Status:
COMPLETED

Trial end date:
2023-07-26

Target enrollment:

Participant gender:

Summary

A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WPV01 and WPV01 Co-administrated With Ritonavir in Healthy Adult Subjects.

Phase:

PHASE1

Details

Lead Sponsor:

Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Treatments:

Ritonavir